Feasibility of neuropsychological assessment in leukaemia patients shortly after diagnosis: directions for future prospective research.
OBJECTIVE
To study neuropsychological functioning of newly diagnosed children with acute lymphoblastic leukaemia (ALL) within two weeks after diagnosis in order to determine the feasibility of a sibling controlled prospective study design.


METHODS
Fifty consecutive patients (median age at testing 6.6 years, range 4-12) were included in a prospective, longitudinal, nationwide study. Treatment would include intrathecal and systemic chemotherapy according to the DCLSG ALL-9 protocol. Children were evaluated with an extensive neuropsychological battery including measures of intelligence, memory, attention, language, visual-constructive function, and fine-motor abilities within two weeks after start of the chemotherapy. The control group consisted of 29 healthy siblings (median age at testing 8.2 years, range 4-12), who were tested <4 weeks after the patients' assessment.


RESULTS
Mean scores on Wechsler Intelligence Scales did not differ significantly between patients and siblings; mean IQ scores for both the patients and the controls were high average. To examine specific neuropsychological functions, norm scores based on the exact age were acquired by fitting procedures, but no significant differences were found.


CONCLUSIONS
Neuropsychological assessment of patients during early hospitalisation is feasible. The results indicate no adverse effect of illness and psychological factors on IQ and neuropsychological functioning of patients with recently diagnosed ALL. The prospective design of this study of cognitive late effects of chemotherapy will allow discrimination between adverse sequelae of disease and treatment.
Jansen
N C
NC
Department of Paediatric Haematology Oncology, Groningen University Hospital, Groningen, Netherlands. N.C.A.Jansen@wkz.azu.nl
Kingma
A
A
Tellegen
P
P
van Dommelen
R I
RI
Bouma
A
A
Veerman
A
A
Kamps
W A
WA
D002648:Child; D002675:Child, Preschool; D004812:Epidemiologic Methods; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000175:diagnosis*; D009422:Nervous System Diseases / Q000175:diagnosis*; D009483:Neuropsychological Tests / Q000592:standards*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000523:psychology*
Leukemia. 2000 Dec;14(12):2240-6
11187915
J Pediatr Psychol. 2001 Jan-Feb;26(1):1-9
11145727
Leukemia. 2002 Jun;16(6):1099-111
12040440
J Clin Exp Neuropsychol. 1986 Jun;8(3):219-28
3722348
Med Pediatr Oncol. 2002 May;38(5):320-8
11979456
J Clin Oncol. 1996 Oct;14(10):2826-35
8874345
J Clin Oncol. 1996 Mar;14(3):911-8
8622039
Curr Opin Oncol. 2000 Jan;12(1):3-12
10687723
J Pediatr. 2001 Sep;139(3):413-20
11562622
J Pediatr Hematol Oncol. 2002 Feb;24(2):106-14
11990695
Arch Clin Neuropsychol. 1999 Aug;14(6):545-59
14590582
Br J Haematol. 2002 Aug;118(2):445-55
12139731
J Clin Oncol. 1991 Aug;9(8):1348-56
2072138